|
| sodium:(2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoate Basic information |
Product Name: | sodium:(2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoate | Synonyms: | sodium:(2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoate;Irinotecan Impurity 35 Sodium Salt;(S)-2-(2-(([1,4'-bipiperidine];Irinotecan Carboxylic Acid Sodium Salt;Irinotecan hydrolyzes ring-opening Impurity;Irinotecan Carboxylic Acid;sodium (S)-2-(2-(([1,4'-bipiperidine]-1'-carbonyl)oxy)-12-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl)-2-hydroxybutanoate;(S)-2-(2-(([1,4'-bipiperidine]-1'-carbonyl)oxy)-12-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl)-2-hydroxybutanoic acid? (Irinotecan Impurity) | CAS: | 1329502-92-2 | MF: | C33H41N4NaO7 | MW: | 628.7 | EINECS: | | Product Categories: | | Mol File: | 1329502-92-2.mol | |
| sodium:(2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoate Chemical Properties |
solubility | DMSO (Slightly), Water (Slightly) | form | Solid | color | Off-White to Pale Yellow | Stability: | Hygroscopic |
| sodium:(2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoate Usage And Synthesis |
Uses | Carboxylate form of Irinotecan, a DNA topoisomerase inhibitor. |
| sodium:(2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoate Preparation Products And Raw materials |
|